BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9604850)

  • 1. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis.
    Furusawa S; Wu J; Fujimura T; Nakano S; Nemoto S; Takayanagi M; Sasaki K; Takayanagi Y
    Methods Find Exp Clin Pharmacol; 1998 Mar; 20(2):87-97. PubMed ID: 9604850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells.
    Fujimura T; Shibata H; Maekawa I; Furusawa S; Kawauchi H; Sasaki K; Takayanagi Y
    Jpn J Pharmacol; 1990 Dec; 54(4):464-7. PubMed ID: 2087009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assay of flow cytometry for the effect of cepharanthine on resistance to doxorubicin].
    Kisara S; Hayashi A; Maekawa I; Furusawa S; Takayanagi Y; Sasaki K
    Yakugaku Zasshi; 1992 Nov; 112(11):837-45. PubMed ID: 1484349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
    Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
    Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
    Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cepharanthine on doxorubicin cytotoxicity in P388 murine leukemia cells in vitro and in vivo.
    Fujimura T; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):235-8. PubMed ID: 2047569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases.
    Furusawa S; Wu J
    Life Sci; 2007 Feb; 80(12):1073-9. PubMed ID: 17204293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
    Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
    Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
    Ling YH; Priebe W; Perez-Soler R
    Cancer Res; 1993 Apr; 53(8):1845-52. PubMed ID: 8467504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27Kip1.
    Harada K; Supriatno ; Yamamoto S; Kawaguchi S; Yoshida H; Sato M
    Anticancer Res; 2003; 23(2B):1441-8. PubMed ID: 12820407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine.
    Kato T; Suzumura Y
    J Natl Cancer Inst; 1987 Sep; 79(3):527-32. PubMed ID: 3476792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells.
    Gatouillat G; Magid AA; Bertin E; El btaouri H; Morjani H; Lavaud C; Madoulet C
    Phytomedicine; 2015 Dec; 22(13):1186-94. PubMed ID: 26598918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced by doxorubicin and cinchonine in P388 multidrug-resistant cells.
    Furusawa S; Nakano S; Wu J; Sakaguchi S; Takayanagi M; Sasaki KI; Satoh S
    J Pharm Pharmacol; 2001 Jul; 53(7):1029-39. PubMed ID: 11480538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma.
    Nakajima A; Yamamoto Y; Taura K; Hata K; Fukumoto M; Uchinami H; Yonezawa K; Yamaoka Y
    Int J Oncol; 2004 Mar; 24(3):635-45. PubMed ID: 14767548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells.
    Sakaguchi S; Furusawa S; Wu J; Nagata K
    Int Immunopharmacol; 2007 Feb; 7(2):191-7. PubMed ID: 17178386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 and mdr-1 gene expression during doxorubicin-induced apoptosis in murine leukemic P388 and P388/R84 cells.
    Ramachandran C; You W; Krishan A
    Anticancer Res; 1997; 17(5A):3369-76. PubMed ID: 9413174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells.
    Ikeda R; Che XF; Yamaguchi T; Ushiyama M; Zheng CL; Okumura H; Takeda Y; Shibayama Y; Nakamura K; Jeung HC; Furukawa T; Sumizawa T; Haraguchi M; Akiyama S; Yamada K
    Cancer Sci; 2005 Jun; 96(6):372-6. PubMed ID: 15958061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.